A carregar...
Ranolazine Attenuates Behavioral Signs of Neuropathic Pain
Ranolazine modulates the cardiac voltage-gated sodium channel (Na(v) 1.5) and is FDA-approved for the treatment of ischemic heart disease. Ranolazine also targets neuronal (Na(v) 1.7, 1.8) isoforms that are implicated in neuropathic pain. Therefore, we determined the analgesic efficacy of ranolazine...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2975014/ https://ncbi.nlm.nih.gov/pubmed/19773645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FBP.0b013e3283323c90 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|